L'Hay-les-Roses, France

Philippe Michel Manoury


Average Co-Inventor Count = 3.1

ph-index = 9

Forward Citations = 301(Granted Patents)


Location History:

  • L'Hay-les-Roses, FR (1976 - 1982)
  • Le Plessis-Robinson, FR (1980 - 1984)
  • Verrierres le Buisson, FR (1990)
  • Verrieres le Buisson, FR (1987 - 1999)

Company Filing History:


Years Active: 1976-1999

Loading Chart...
39 patents (USPTO):Explore Patents

Title: Philippe Michel Manoury: A Pioneer in Pharmaceutical Innovations

Introduction

Philippe Michel Manoury, based in L'Hay-les-Roses, France, is a prolific inventor with an impressive portfolio of 39 patents. His work primarily focuses on pharmaceutical innovations, contributing to advancements in therapeutic compounds.

Latest Patents

Among his recent patents are noteworthy inventions such as 1-(2-(2,3-Dihydro-1H-inden-1-yl)ethyl)-4-(naphthalen-1-yl)piperazine and a variety of 2-aminopyrimidine-4-carboxamide derivatives. These patents also cover compounds with a general formula featuring variables like n, X, R, and R1-2, providing possible options for therapeutic use, targeting various medical conditions through innovative compositions.

Career Highlights

Manoury has had a distinguished career, working with reputable companies such as Synthelabo and L'Oréal. His contributions to pharmaceutical development have been pivotal, reinforcing his reputation as a leading inventor in his field.

Collaborations

Throughout his career, Philippe has collaborated with distinguished colleagues such as Henry Najer and Jean Louis Binet, enhancing the innovative capabilities and expertise of the teams he has been a part of, thus fostering a collaborative atmosphere that drives success in patentable inventions.

Conclusion

Philippe Michel Manoury stands out as a key player in the world of pharmaceutical inventions. His extensive patent portfolio showcases his commitment to developing innovative therapeutic solutions. Through his successful career and collaborations, he continues to influence the pharmaceutical industry significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…